Neuropsychological outcome after cardiac arrest: a prospective case control sub-study of the Targeted hypothermia versus targeted normothermia after out-of-hospital cardiac arrest trial (TTM2)

Blennow Nordström, Erik and Lilja, Gisela and Vestberg, Susanna and Ullén, Susann and Friberg, Hans and Nielsen, Niklas and Heimburg, Katarina and Evald, Lars and Mion, Marco and Segerström, Magnus and Grejs, Anders M. and Keeble, Thomas R. and Kirkegaard, Hans and Ljung, Hanna and Rose, Sofia and Wise, Matthew P. and Rylander, Christian and Undén, Johan and Cronberg, Tobias (2020) Neuropsychological outcome after cardiac arrest: a prospective case control sub-study of the Targeted hypothermia versus targeted normothermia after out-of-hospital cardiac arrest trial (TTM2). BMC Cardiovascular Disorders, 20 (1). p. 439. ISSN 1471-2261

[img]
Preview
Text
Published Version
Available under the following license: Creative Commons Attribution.

Download (728kB) | Preview
Official URL: https://doi.org/10.1186/s12872-020-01721-9

Abstract

Background: This study is designed to provide detailed knowledge on cognitive impairment after out-of-hospital cardiac arrest (OHCA) and its relation to associated factors, and to validate the neurocognitive screening of the Targeted Hypothermia versus Targeted Normothermia after Out-of-Hospital Cardiac Arrest trial (TTM2-trial), assessing effectiveness of targeted temperature management after OHCA. Methods: This longitudinal multi-center clinical study is a sub-study of the TTM2-trial, in which a comprehensive neuropsychological examination is performed in addition to the main TTM2-trial neurocognitive screening. Approximately 7 and 24 months after OHCA, survivors at selected study sites are invited to a standardized assessment, including performance-based tests of cognition and questionnaires of emotional problems, fatigue, executive function and insomnia. At 1:1 ratio, a matched control group from a cohort of acute myocardial infarction (MI) patients is recruited to perform the same assessment. We aim to include 100 patients per group. Potential differences between the OHCA patients and the MI controls at 7 and 24 months will be analyzed with a linear regression, using composite z-scores per cognitive domain (verbal, visual/constructive, working memory, episodic memory, processing speed, executive functions) as primary outcome measures. Results from OHCA survivors on the main TTM2-trial neurocognitive screening battery will be compared with neuropsychological test results at 7 months, using sensitivity and specificity analyses. Discussion: In this study we collect detailed information on cognitive impairment after OHCA and compare this to a control group of patients with acute MI. The validation of the TTM2 neurocognitive screening battery could justify its inclusion in routine follow-up. Our results may have a potential to impact on the design of future follow-up strategies and interventions after OHCA.

Item Type: Journal Article
Keywords: cardiac arrest, cognitive dysfunction, neuropsychological tests, outcome, cognitive screening
Faculty: Faculty of Health, Education, Medicine & Social Care
Depositing User: Ian Walker
Date Deposited: 09 Oct 2020 07:59
Last Modified: 09 Sep 2021 18:52
URI: https://arro.anglia.ac.uk/id/eprint/705971

Actions (login required)

Edit Item Edit Item